Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederroche.com
Get the latest updates from Investor Update directly as they happen.
Follow now 333 followers
Last updated 7 days ago
7 days ago
We are pleased to invite investors and analysts to participate in our...
10 days ago
Nearly half of patients on Gazyva/Gazyvaro plus standard therapy achieved a complete...
12 days ago
Susvimo is the first and only continuous delivery treatment that offers an...
14 days ago
We are pleased to invite investors and analysts to participate in our...
18 days ago
Basel, 30 January 2025 Group sales grew by 7%1 at constant exchange...
18 days ago
Group sales grew by 7%1 at constant exchange rates (CER; 3% in...
18 days ago
Basel, 30 January 2025 Group sales grew by 7%1 at constant exchange...
20 days ago
Updated overall survival (OS) results - a key secondary endpoint - reinforce...
21 days ago
Across three key functional outcomes, North Star Ambulatory Assessment (NSAA), Time to...
25 days ago
Roche will publish its Full Year Results of 2024 prior to the...
26 days ago
More than 1 million curable sexually transmitted infections (STIs) are acquired every...
about 1 month ago
Basel, 8 January 2025 – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced...